RCM
BIIB icon

Raleigh Capital Management’s Biogen BIIB Stock Holding History

Raleigh Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-71
Closed -$10.9K – 625
2024
Q4 		$10.9K Buy
71
+17
+31% +$2.87K ﹤0.01% 599
2024
Q3 		$10.5K Sell
54
-41
-43% -$8.58K ﹤0.01% 583
2024
Q2 		$22K Buy
95
+47
+98% +$10.2K 0.01% 417
2024
Q1 		$10.3K Buy
48
+18
+60% +$4.22K ﹤0.01% 558
2023
Q4 		$7.76K Buy
30
+5
+20% +$1.23K ﹤0.01% 653
2023
Q3 		$6.42K Hold
25
– – ﹤0.01% 638
2023
Q2 		$7.12K Buy
+25
New +$7.44K ﹤0.01% 556

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return